Search Results - "Bazzan, Mario"

Impact of residual pulmonary obstruction on the long-term outcome of patients with pulmonary embolism by Pesavento, Raffaele, Filippi, Lucia, Palla, Antonio, Visonà, Adriana, Bova, Carlo, Marzolo, Marco, Porro, Fernando, Villalta, Sabina, Ciammaichella, Maurizio, Bucherini, Eugenio, Nante, Giovanni, Battistelli, Sandra, Muiesan, Maria Lorenza, Beltramello, Giampietro, Prisco, Domenico, Casazza, Franco, Ageno, Walter, Palareti, Gualtiero, Quintavalla, Roberto, Monti, Simonetta, Mumoli, Nicola, Zanatta, Nello, Cappelli, Roberto, Cattaneo, Marco, Moretti, Valentino, Corà, Francesco, Bazzan, Mario, Ghirarduzzi, Angelo, Frigo, Anna Chiara, Miniati, Massimo, Prandoni, Paolo

“…The impact of residual pulmonary obstruction on the outcome of patients with pulmonary embolism is uncertain.We recruited 647 consecutive symptomatic patients…”
Get full text

Fondaparinux-related thrombocytopenia in a previous low-molecular-weight heparin (LMWH)-induced heparin-induced thrombocytopenia (HIT) by Rota, Eugenia, Bazzan, Mario, Fantino, Giovanni

Get more information

Antiphospholipid Antibodies and Infection: Non Nova Sed Nove by Sciascia, Savino, Radin, Massimo, Bazzan, Mario, Montaruli, Barbara, Cosseddu, Domenico, Norbiato, Claudio, Bertero, Maria Tiziana, Carignola, Renato, Bacco, Beatrice, Gallo Cassarino, Silvia, Roccatello, Dario

“…The clinical significance of antiphospholipid antibodies (aPL) in the context of infections has attracted attention since their first discovery in patients…”
Get full text

Low ADAMTS 13 plasma levels are predictors of mortality in COVID-19 patients by Bazzan, Mario, Montaruli, Barbara, Sciascia, Savino, Cosseddu, Domenico, Norbiato, Claudio, Roccatello, Dario

Get full text

Low ADAMTS 13 plasma levels are predictors of mortality in COVID-19 patients by Bazzan, Mario, Montaruli, Barbara, Sciascia, Savino, Cosseddu, Domenico, Norbiato, Claudio, Roccatello, Dario

Get full text

Enoxaparin for the Prevention of Venous Thromboembolism Associated With Central Vein Catheter: A Double-Blind, Placebo-Controlled, Randomized Study in Cancer Patients by VERSO, Melina, AGNELLI, Giancarlo, SANTORO, Armando, IMBERTI, Davide, SORARU, Mariella, MOSCA, Stefano, BERTOGLIO, Sergio, DI SOMMA, Franco C, PAOLETTI, Francesco, AGENO, Walter, BAZZAN, Mario, PARISE, Pasquale, QUINTAVALLA, Roberto, NAGLIERI, Emanuele

“…The extent of venous thromboembolism (VTE) associated with central vein catheters (CVC) in cancer patients remains unclear. The aim of this study was to…”
Get full text

Diagnosis of del(5q) MDS, 14 Years after JAK-2 Positive PV Appearance: Complete Remission of both Diseases with Lenalidomide Monotherapy by Vaccarino, Antonella, Dogliotti, Irene, Marletto, Fabio, Demarchi, Andrea, Bazzan, Mario

“…This is the report of the clinical case of a patient who presents the association of a JAK-2 positive chronic myeloproliferative neoplasia to a subsequent 5q-…”
Get full text

Duration of anticoagulant treatment and recurrence of venous thromboembolism in patients with and without thrombophilic abnormalities by Taliani, Maria Rita, Becattini, Cecilia, Agnelli, Giancarlo, Prandoni, Paolo, Moia, Marco, Bazzan, Mario, Salvi, Rosamaria, Ageno, Walter, Guazzaloca, Giuliana, Imberti, Davide, Silingardi, Mauro, Poggio, Renzo

Get more information

Spleen neoangiogenesis in patients with myelofibrosis with myeloid metaplasia by Barosi, Giovanni, Vittorio, Rosti, Margherita, Massa, Luca, Viarengo G., Alessandro, Pecci, Vittorio, Necchi, Isabella, Ramaioli, Rita, Campanelli, Monia, Marchetti, Mario, Bazzan, Umberto, Magrini

“…Summary Neoangiogenesis is an integral component of bone marrow myeloproliferation in patients with myelofibrosis with myeloid metaplasia (MMM). As…”
Get full text

Anticoagulant therapy in venous thromboembolism and bleeding risk: focus on the use of predictive scores. by Cavagna, Laura M, Bazzan, Mario

“…The standard treatment for venous thromboembolism (Vte) is anticoagulation. Drug selection and treatment duration will depend on the clinical presentation, the…”
Get more information

Systemic lupus erythematosus and thrombosis by Bazzan, Mario, Vaccarino, Antonella, Marletto, Fabio

“…Systemic Lupus Erythematosus (SLE) is an acquired, multiorgan, autoimmune disease. Clinical presentation is extremely variable and heterogeneous. It has been…”
Get full text

Antiphospholipid Syndrome Is Still a Rare Disease—Estimated Prevalence in the Piedmont and Aosta Valley Regions of Northwest Italy: Comment on the Article by Duarte‐García et al by Radin, Massimo, Sciascia, Savino, Bazzan, Mario, Bertero, Tiziana, Carignola, Renato, Montabone, Erika, Montaruli, Barbara, Vaccarino, Antonella, Cecchi, Irene, Rubini, Elena, Roccatello, Dario, Baldovino, Simone

Get full text

Identifying phenotypes of patients with antiphospholipid antibodies: results from a cluster analysis in a large cohort of patients by Sciascia, Savino, Radin, Massimo, Cecchi, Irene, Bertolaccini, Maria Laura, Bertero, Maria Tiziana, Rubini, Elena, Vaccarino, Antonella, Bazzan, Mario, Giachino, Osvaldo, Baldovino, Simone, Rossi, Daniela, Mengozzi, Giulio, Roccatello, Dario

“…Abstract Objectives To identify the aggregation of patients with aPL into different subgroups sharing common features in terms of clinical and laboratory…”
Get full text

Long-term effect of B-cells depletion alone as rescue therapy for severe thrombocytopenia in primary antiphospholipid syndrome by Sciascia, Savino, Radin, Massimo, Cecchi, Irene, Rubini, Elena, Bazzan, Mario, Roccatello, Dario

“…To investigate the long-term effect of B-cell depletion therapy with Rituximab (RTX) alone as rescue therapy in primary antiphospholipid syndrome (PAPS)…”
Get full text

Genetic and molecular evidence for complement dysregulation in patients with HELLP syndrome by Bazzan, Mario, Todros, Tullia, Tedeschi, Silvana, Ardissino, Gianluigi, Cardaropoli, Simona, Stella, Stefania, Montaruli, Barbara, Marchese, Cristiana, Roccatello, Dario, Cugno, Massimo

“…HELLP (Hemolysis, elevated liver enzymes and low platelets) syndrome is a severe and acute pregnancy-related disorder that occurs in approximately 2.5 per 1000…”
Get full text

Novel diagnostic and therapeutic frontiers in thrombotic anti-phospholipid syndrome by Sciascia, Savino, Radin, Massimo, Bazzan, Mario, Roccatello, Dario

“…The anti-phospholipid syndrome (APS) is an autoimmune disorder characterized by vascular thrombosis and/or pregnancy morbidity, associated with a persistent…”
Get full text

Outpatient percutaneous native renal biopsy: safety profile in a large monocentric cohort by Roccatello, Dario, Sciascia, Savino, Rossi, Daniela, Naretto, Carla, Bazzan, Mario, Solfietti, Laura, Baldovino, Simone, Menegatti, Elisa

“…ObjectivesWe aim to evaluate the safety of performing percutaneous native kidney biopsy (PKB) as an outpatient procedure (implying an observation period of 6…”
Get full text

Prevalence of the Antiphospholipid Antibodies in Young Adults with Ischemic Stroke by Vaccarino, Antonella, Pagliaro, Maria, Rollone, Clara, Melis, Fabio, De Marco, Federica, Savio, Katia, Guido, Marilena, Bazzan, Mario, Imperiale, Daniele, Pini, Massimo

“…Background: Ischemic stroke is rare in young adults, with an incidence of about 10-15% of all the ischemic strokes. In about one third of these patients a…”
Get full text

Inhibitory anti ADAMTS13 antibodies with a new rapid fully automated CLiA assay by Montaruli, Barbara, Novelli, Chiara, Solfietti, Laura, Valpreda, Alessandra, Bazzan, Mario, Luigi Andrea Beverina, Ivo, Brando, Bruno, Roccatello, Dario, Cosseddu, Domenico

“…Background Thrombotic thrombocytopenic purpura (TTP) is a life‐threatening disorder characterized by severe ADAMTS13 deficiency. The acquired form is…”
Get full text

Acute renal infarction: a single center experience by Mesiano, Paola, Rollino, Cristiana, Beltrame, Giulietta, Ferro, Michela, Quattrocchio, Giacomo, Fenoglio, Roberta, Pozzato, Marco, Cecere, Pasqualina, Forneris, Giacomo, Bazzan, Mario, Macchia, Gianluca, Roccatello, Dario

“…Background Acute renal infarction is a rare condition whose diagnosis is often delayed. Major risk factors include atrial fibrillation, valvular or ischemic…”
Get full text